Rousseau B, Bhaduri-McIntosh S
Viruses. 2023; 15(4).
PMID: 37112929
PMC: 10141000.
DOI: 10.3390/v15040949.
Lin L, Juillard P, Hawke S, Marsh-Wakefield F, Grau G
Int J Mol Sci. 2023; 24(7).
PMID: 37047460
PMC: 10094666.
DOI: 10.3390/ijms24076487.
Land W
Genes Immun. 2023; 24(2):57-70.
PMID: 36750753
DOI: 10.1038/s41435-023-00198-8.
Li Z, Chen A, Wan H, Gao X, Li C, Xiong L
ACS Chem Neurosci. 2023; 14(3):400-417.
PMID: 36657737
PMC: 9897217.
DOI: 10.1021/acschemneuro.2c00540.
Constant O, Maarifi G, Barthelemy J, Martin M, Tinto B, Savini G
Emerg Microbes Infect. 2022; 12(1):2156815.
PMID: 36495563
DOI: 10.1080/22221751.2022.2156815.
The complex role of inflammation and gliotransmitters in Parkinson's disease.
Gopinath A, Mackie P, Phan L, Tansey M, Khoshbouei H
Neurobiol Dis. 2022; 176:105940.
PMID: 36470499
PMC: 10372760.
DOI: 10.1016/j.nbd.2022.105940.
Crosstalk between dendritic cells and regulatory T cells: Protective effect and therapeutic potential in multiple sclerosis.
Li R, Li H, Yang X, Hu H, Liu P, Liu H
Front Immunol. 2022; 13:970508.
PMID: 36177043
PMC: 9513370.
DOI: 10.3389/fimmu.2022.970508.
Metabolic Reprogramming of Innate Immune Cells as a Possible Source of New Therapeutic Approaches in Autoimmunity.
Mohammadnezhad L, Shekarkar Azgomi M, La Manna M, Sireci G, Rizzo C, Badami G
Cells. 2022; 11(10).
PMID: 35626700
PMC: 9140143.
DOI: 10.3390/cells11101663.
Role of Dendritic Cells in Viral Brain Infections.
Constant O, Maarifi G, Blanchet F, Van de Perre P, Simonin Y, Salinas S
Front Immunol. 2022; 13:862053.
PMID: 35529884
PMC: 9072653.
DOI: 10.3389/fimmu.2022.862053.
Inhibitory effects of tolerogenic probiotics on migratory potential of lupus patient-derived DCs.
Esmaeili S, Taheri R, Mahmoudi M, Momtazi-Borojeni A, Morshedi M, Bahramifar A
Iran J Basic Med Sci. 2022; 24(11):1509-1514.
PMID: 35317107
PMC: 8917844.
DOI: 10.22038/IJBMS.2021.58438.12982.
Dendritic Cell-Targeted Therapies to Treat Neurological Disorders.
Hussain A, Rafeeq H, Munir N, Jabeen Z, Afsheen N, Rehman K
Mol Neurobiol. 2021; 59(1):603-619.
PMID: 34743292
DOI: 10.1007/s12035-021-02622-4.
Integrin-dependent migratory switches regulate the translocation of Toxoplasma-infected dendritic cells across brain endothelial monolayers.
Ross E, Ten Hoeve A, Barragan A
Cell Mol Life Sci. 2021; 78(12):5197-5212.
PMID: 34023934
PMC: 8254729.
DOI: 10.1007/s00018-021-03858-y.
Organic Selenium Reaches the Central Nervous System and Downmodulates Local Inflammation: A Complementary Therapy for Multiple Sclerosis?.
de Toledo J, de Campos Fraga-Silva T, Borim P, de Oliveira L, Oliveira E, Perico L
Front Immunol. 2020; 11:571844.
PMID: 33193354
PMC: 7664308.
DOI: 10.3389/fimmu.2020.571844.
Conditional Silencing of H-2D Class I Molecule Expression Modulates the Protective and Pathogenic Kinetics of Virus-Antigen-Specific CD8 T Cell Responses during Theiler's Virus Infection.
Tritz Z, Orozco R, Malo C, Ayasoufi K, Fain C, Khadka R
J Immunol. 2020; 205(5):1228-1238.
PMID: 32737149
PMC: 7981782.
DOI: 10.4049/jimmunol.2000340.
Three-Dimensional Explant Platform for Studies on Choroid Plexus Epithelium.
Petersen N, Torz L, Jensen K, Hjorto G, Spiess K, Rosenkilde M
Front Cell Neurosci. 2020; 14:108.
PMID: 32431599
PMC: 7214744.
DOI: 10.3389/fncel.2020.00108.
Environmental Signals on Microglial Function during Brain Development, Neuroplasticity, and Disease.
da Silva Chagas L, Sandre P, Ribeiro E Ribeiro N, Marcondes H, Oliveira Silva P, Savino W
Int J Mol Sci. 2020; 21(6).
PMID: 32204421
PMC: 7139373.
DOI: 10.3390/ijms21062111.
On the road to new treatments for multiple sclerosis: targeting dendritic cell migration into the central nervous system.
Meena M, Cools N
Neural Regen Res. 2019; 14(12):2088-2090.
PMID: 31397344
PMC: 6788248.
DOI: 10.4103/1673-5374.262583.
Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders.
Fantuzzi L, Tagliamonte M, Gauzzi M, Lopalco L
Cell Mol Life Sci. 2019; 76(24):4869-4886.
PMID: 31377844
PMC: 6892368.
DOI: 10.1007/s00018-019-03255-6.
Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell Functions.
Melnikov M, Rogovskii V, Boyko A, Pashenkov M
J Neuroimmune Pharmacol. 2019; 15(1):37-47.
PMID: 31011885
DOI: 10.1007/s11481-019-09852-3.
Effective effectors: How T cells access and infiltrate the central nervous system.
Congdon K, Sanchez-Perez L, Sampson J
Pharmacol Ther. 2018; 197:52-60.
PMID: 30557632
PMC: 7164682.
DOI: 10.1016/j.pharmthera.2018.12.007.